263 related articles for article (PubMed ID: 21284527)
1. Vascular endothelial growth factors in retinal and choroidal neovascular diseases.
Kinnunen K; Ylä-Herttuala S
Ann Med; 2012 Feb; 44(1):1-17. PubMed ID: 21284527
[TBL] [Abstract][Full Text] [Related]
2. VEGF is clearly an exciting point of attack in the treatment of neovascular diseases of the retina and choroid.
Coimbra JC
Ophthalmologica; 2012; 227 Suppl 1():1. PubMed ID: 22645747
[No Abstract] [Full Text] [Related]
3. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
4. Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis.
Todorich B; Yiu G; Hahn P
Expert Rev Clin Pharmacol; 2014 May; 7(3):375-91. PubMed ID: 24580084
[TBL] [Abstract][Full Text] [Related]
5. [Experience with vascular endothelial growth factor inhibitors used in ophthalmologic care].
Khalaim AV; Stoliarenko GE
Vestn Oftalmol; 2007; 123(5):54-6, preceding 56. PubMed ID: 18078062
[No Abstract] [Full Text] [Related]
6. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy.
Zhang SX; Ma JX
Prog Retin Eye Res; 2007 Jan; 26(1):1-37. PubMed ID: 17074526
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Ciulla TA; Rosenfeld PJ
Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
[TBL] [Abstract][Full Text] [Related]
8. Retinal and choroidal microangiopathies: therapeutic opportunities.
Afzal A; Shaw LC; Ljubimov AV; Boulton ME; Segal MS; Grant MB
Microvasc Res; 2007; 74(2-3):131-44. PubMed ID: 17585951
[TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
Andreoli CM; Miller JW
Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
[TBL] [Abstract][Full Text] [Related]
10. Ocular neovascularization: basic mechanisms and therapeutic advances.
Dorrell M; Uusitalo-Jarvinen H; Aguilar E; Friedlander M
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S3-19. PubMed ID: 17240254
[TBL] [Abstract][Full Text] [Related]
11. Systemic safety of bilateral intravitreal anti-vascular endothelial growth factor injections.
Freund KB; Vance SK
Retina; 2011 Jan; 31(1):1-3. PubMed ID: 21187729
[No Abstract] [Full Text] [Related]
12. Role of vascular endothelial growth factor in ocular angiogenesis.
Shams N; Ianchulev T
Ophthalmol Clin North Am; 2006 Sep; 19(3):335-44. PubMed ID: 16935208
[TBL] [Abstract][Full Text] [Related]
13. An evidence-based review of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 2. Coats' disease, best disease, and uveitis with childhood neovascularization.
Chaudhary KM; Mititelu M; Lieberman RM
J Pediatr Ophthalmol Strabismus; 2013; 50(1):11-9. PubMed ID: 22938515
[TBL] [Abstract][Full Text] [Related]
14. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
[TBL] [Abstract][Full Text] [Related]
15. [Neovascularization in ocular tissues: mechanisms and role of proangiogenic and antiangiogenic factors].
Nowak JZ; Wiktorowska-Owczarek A
Klin Oczna; 2004; 106(1-2):90-7. PubMed ID: 15218775
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor biology: clinical implications for ocular treatments.
Bhisitkul RB
Br J Ophthalmol; 2006 Dec; 90(12):1542-7. PubMed ID: 17114590
[TBL] [Abstract][Full Text] [Related]
17. Ocular angiogenesis: the role of growth factors.
Kvanta A
Acta Ophthalmol Scand; 2006 Jun; 84(3):282-8. PubMed ID: 16704684
[TBL] [Abstract][Full Text] [Related]
18. Development and pathology of the hyaloid, choroidal and retinal vasculature.
Saint-Geniez M; D'Amore PA
Int J Dev Biol; 2004; 48(8-9):1045-58. PubMed ID: 15558494
[TBL] [Abstract][Full Text] [Related]
19. microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.
Yang C; Tahiri H; Cai C; Gu M; Gagnon C; Hardy P
Cardiovasc Ther; 2018 Jun; 36(3):e12329. PubMed ID: 29608244
[TBL] [Abstract][Full Text] [Related]
20. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
